Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

albumin

  • Open Access
    Factors Associated With Mortality in Patients With Catheter-related Bloodstream Infection: A Multicenter Retrospective Study
    AKIHIKO FUTAMURA, TAKENAO KOSEKI, TSUYOSHI NAKAI, NOBUYUKI MUROI, MICHIAKI MYOTOKU, JUNICHI IIDA, HIROKI MAKI, AKITO SUZUKI, KAZUHISA MIZUTANI, HIKARU OGINO, YASUKI TANIGUCHI, KEIICHIRO HIGASHI and MASANOBU USUI
    In Vivo November 2024, 38 (6) 3041-3049; DOI: https://doi.org/10.21873/invivo.13788
  • Open Access
    The Clinical Impact of Hemoglobin, Albumin, Lymphocyte, Platelet (HALP) in Gastric Cancer Patients Who Receive Curative Treatment
    TORU AOYAMA, YUKIO MAEZAWA, ITARU HASHIMOTO, RYUKI ESASHI, SOSUKE YAMAMOTO, MAMORU UCHIYAMA, KOJI NUMATA, KEISUKE KAZAMA, AYAKO TAMAGAWA, AYA SAITO and NORIO YUKAWA
    In Vivo September 2024, 38 (5) 2494-2500; DOI: https://doi.org/10.21873/invivo.13720
  • Open Access
    The Clinical Impact of the Pretreatment Albumin to Fibrinogen Ratio in Esophageal Cancer Patients Who Receive Curative Treatment
    TORU AOYAMA, YUKIO MAEZAWA, ITARU HASHIMOTO, KENTARO HARA, KEISUKE KAZAMA, KEISUKE KOMORI, AYA KATO, KAZUKI OTANI, AYAKO TAMAGAWA, HARUHIKO CHO, JUNYA MORITA, SHINNOSUKE KAWAHARA, MIE TANABE, TAKASHI OSHIMA, AYA SAITO, NORIO YUKAWA and YASUSHI RINO
    In Vivo May 2024, 38 (3) 1253-1259; DOI: https://doi.org/10.21873/invivo.13562
  • Open Access
    Survival Predictors Before Preoperative Adjuvant Chemotherapy in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma
    ITARU HASHIMOTO, KAZUKI KANO, HIDEAKI SUEMATSU, TAKANOBU YAMADA, HAYATO WATANABE, KYOHEI KANEMATSU, SHINSUKE NAGASAWA, TORU AOYAMA, TAKASHI OGATA, YASUSHI RINO, AYA SAITO and TAKASHI OSHIMA
    In Vivo March 2024, 38 (2) 881-889; DOI: https://doi.org/10.21873/invivo.13514
  • Open Access
    Albumin-Globulin Ratio Is an Independent Prognostic Factor for Gastric Cancer Patients who Received Curative Treatment
    MOMOKO FUKUDA, TORU AOYAMA, ITARU HASHIMOTO, YUKIO MAEZAWA, AYA KATO, KENTARO HARA, KEISUKE KAZAMA, KEISUKE KOMORI, AYAKO TAMAGAWA, HARUHIKO CHO, TETSUSHI ISHIGURO, KENKI SEGAMI, MASATO NAKAZONO, KAZUKI OTANI, SHO SAWAZAKI, MASAKATSU NUMATA, SHINNOSUKE KAWAHARA, TAKASHI OSHIMA, AYA SAITO, NORIO YUKAWA and YASUSHI RINO
    In Vivo March 2024, 38 (2) 904-910; DOI: https://doi.org/10.21873/invivo.13517
  • Open Access
    Serum Albumin Affects the Time-to-treatment Failure of Alectinib: A Multicenter Retrospective Study
    KENGO UMEHARA, KAORI YAMA, KEISUKE GOTO, TAKANOBU HOSHI, TOMOAKI HATAKEYAMA, MARIKO ISAJI, SHINYA TAKADA, KAYO YAMAGISHI, KOZO MINO and HIDEKI SATO
    In Vivo September 2023, 37 (5) 2260-2267; DOI: https://doi.org/10.21873/invivo.13328
  • Open Access
    Pre-treatment CRP and Albumin Determines Prognosis for Unresectable Advanced Oesophageal Cancer
    MAKOTO SOHDA, MAKOTO SAKAI, ARISA YAMAGUCHI, TAKAYOSHI WATANABE, NOBUHIRO NAKAZAWA, YASUNARI UBUKATA, KENGO KURIYAM, AKIHIKO SANO, TAKEHIKO YOKOBORI, HIROOMI OGAWA, KEN SHIRABE and HIROSHI SAEKI
    In Vivo July 2022, 36 (4) 1930-1936; DOI: https://doi.org/10.21873/invivo.12914
  • Open Access
    Clinical Impact of Preoperative Albumin-Bilirubin Status in Esophageal Cancer Patients Who Receive Curative Treatment
    TORU AOYAMA, MIHWA JU, DAISUKE MACHIDA, KEISUKE KOMORI, HIROSHI TAMAGAWA, AYAKO TAMAGAWA, YUKIO MAEZAWA, KAZUKI KANO, KENTARO HARA, KENKI SEGAMI, ITARU HASHIMOTO, SHINSUKE NAGASAWA, MASATO NAKAZONO, TAKASHI OSHIMA, NORIO YUKAWA and YASUSHI RINO
    In Vivo May 2022, 36 (3) 1424-1431; DOI: https://doi.org/10.21873/invivo.12847
  • You have access
    Significance of Glasgow Prognostic Scores in NSCLC Patients Treated With Immunotherapy After Platinum-based Cytotoxic Chemotherapy
    HYE SEON KANG, AH YOUNG SHIN, CHANG DONG YEO, SUNG KYOUNG KIM, CHAN KWON PARK, JU SANG KIM, SEUNG JOON KIM, SANG HAAK LEE and JIN WOO KIM
    In Vivo November 2021, 35 (6) 3423-3430; DOI: https://doi.org/10.21873/invivo.12642
  • You have access
    The Clinical Influence of the C-Reactive Protein-to-Albumin Ratio in Patients Who Received Curative Treatment for Gastric Cancer
    TORU AOYAMA, MASATO NAKAZONO, KENKI SEGAMI, SHINSUKE NAGASAWA, KAZUKI KANO, TAKANOBU YAMADA, YUKIO MAEZAWA, KENTARO HARA, ITARU HASHIMOTO, HIDEAKI SUEMATSU, HAYATO WATANABE, KOSUKE TAKAHASHI, MASAKATSU NUMATA, HIROSHI TAMAGAWA, NORIO YUKAWA, YASUSHI RINO, TAKASHI OGATA and TAKASHI OSHIMA
    In Vivo November 2021, 35 (6) 3475-3482; DOI: https://doi.org/10.21873/invivo.12648

Pages

  • Next
  • 1
  • 2
In Vivo

© 2025 In Vivo

Powered by HighWire